Hengeler Mueller advises Bayer on completed sale of global prescription dermatology business

03. July 2019

LEO Pharma completes the acquisition of Bayer’s prescription dermatology business. The transaction includes the product rights for Bayer’s global prescription dermatology business with the exception of Afghanistan and Pakistan, a production facility in Segrate, Italy, and a total of 347 employees who will join LEO Pharma in addition to the employees who joined from the United States last year.

Hengeler Mueller advised Bayer on the transaction. The team was led by partners Matthias Hentzen and Christian Wentrup (both Corporate/M&A) and included partner Thorsten Mäger (Antitrust) (all Düsseldorf), counsel Gunther Wagner (Tax, Munich) as well as associates Florian Hassner, Gerrit Forst, Daniel Doetsch, and Richard Suermann (all Corporate/M&A, Düsseldorf).